Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$2.3B
Avg Funding
$90.7M
Cities
23

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Menlo Park, United States
$18.0M
raised

Tivic Health is a commercial health tech company that develops bioelectronic medicine to alleviate symptoms of inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$60.0M
raised

Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Naarden, The Netherlands
$452.6M
raised

New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cranbury, United States
$165.0M
raised

Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$602.0M
raised

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Tórtola, Spain
$1.3M
raised

CRISM Therapeutics is a pharmaceutical company that develops ChemoSeed to improve the clinical performance of cancer treatments.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$175.0M
raised

Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chester, United Kingdom
$55.0M
raised

Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Simrishamn, Sweden
$454K
raised

Prebona is a nanotechnology firm that develops products and solutions for the healthcare, transportation, agriculture and textile industry.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Rochelle, France
$9.8M
raised

Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.

Nov 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Seinäjoki, Finland
$1.1M
raised

Eevia Health is a Finnish-Norwegian life science company.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oakville, Canada
$10.7M
raised

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Clermont-ferrand, France
$5.8M
raised

Carbios designs and develops bio-industrial solutions to reinvent the life cycle of plastic and textile polymers.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$150.0M
raised

Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$9.3M
raised

MetaVia is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Halifax, Canada
$532K
raised

Appili Therapeutics is an anti-infective pharmaceutical development company.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Garden City, United States
$5.0M
raised

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$11.0M
raised

FluoGuide provides solutions for maximizing surgical outcome through intelligent targeting.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Spokane, United States
$4.0M
raised

Gridiron BioNutrients is an emerging company in the rapidly-growing CBD hemp-oil industry.

Nov 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miami Beach, United States
$60.0M
raised

Pasithea Therapeutics is a biotechnology company that seeks to solve clinical problems such as mental health.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Fort Worth, United States
$100.0M
raised

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

Nov 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$143.8M
raised

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Nov 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$140.0M
raised

Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

Nov 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alpharetta, United States
$12.5M
raised

Dogwood Therapeutics is a clinical-stage biopharmaceutical company developing novel antiviral therapies for fibromyalgia and other diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Los Angeles, United States
$75.0M
raised

Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 401 to 425 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked